PTPRC and pulmonary fibrosis: For example, CD45 cell therapy was found to be beneficial for treating CCl4-induced liver fibrosis [98], and CD45+ cells were found to alleviate bleomycin-induced pulmonary fibrosis by limiting expansion and activation of group 2 innate lymphoid cells [99].